Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study.

Ichihara K, Masumori N, Iwasawa A, Taguchi K, Yamaguchi Y, Nishimura M, Sasamura H, Suzuki N, Haga K, Miyao N, Hirose T.

Int J Urol. 2018 Oct;25(10):849-854. doi: 10.1111/iju.13757. Epub 2018 Aug 1.

PMID:
30066966
2.

Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.

Hayashi K, Sasamura H, Nakamura M, Sakamaki Y, Azegami T, Oguchi H, Tokuyama H, Wakino S, Hayashi K, Itoh H.

Kidney Int. 2015 Oct;88(4):745-53. doi: 10.1038/ki.2015.178. Epub 2015 Jun 24.

PMID:
26108068
3.

Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.

Oguchi H, Sasamura H, Shinoda K, Morita S, Kono H, Nakagawa K, Ishiguro K, Hayashi K, Nakamura M, Azegami T, Oya M, Itoh H.

Hypertension. 2014 Oct;64(4):784-91. doi: 10.1161/HYPERTENSIONAHA.113.02973. Epub 2014 Jun 30.

PMID:
24980670
4.

KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria.

Hayashi K, Sasamura H, Nakamura M, Azegami T, Oguchi H, Sakamaki Y, Itoh H.

J Clin Invest. 2014 Jun;124(6):2523-37. doi: 10.1172/JCI69557. Epub 2014 May 8.

5.

Feasibility of regression of hypertension using contemporary antihypertensive agents.

Sasamura H, Nakaya H, Julius S, Tomotsugu N, Sato Y, Takahashi F, Takeuchi M, Murakami M, Ryuzaki M, Itoh H; STAR CAST investigators.

Am J Hypertens. 2013 Dec;26(12):1381-8. doi: 10.1093/ajh/hpt105.

PMID:
24190927
6.

Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): rationale, design, and methodology.

Yamano S, Horii M, Takami T, Sakuma M, Morimoto T, Okada S, Taoka T, Kichikawa K, Sasamura H, Itoh H, Furuya Y, Ueno S, Imamura T, Sugiyama S, Ogawa H, Saito Y.

Int J Stroke. 2015 Apr;10(3):452-6. doi: 10.1111/ijs.12085. Epub 2013 Jul 9.

PMID:
23834197
7.

[Current status of vaccination therapy for hypertension].

Sasamura H, Azegami T, Itoh H.

Nihon Rinsho. 2012 Sep;70(9):1627-32. Review. Japanese.

PMID:
23012814
8.

Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartan.

Hayashi K, Sasamura H, Azegami T, Itoh H.

J Atheroscler Thromb. 2012;19(8):736-46. Epub 2012 Apr 28.

9.

'Memory' and 'legacy' in hypertension and lifestyle-related diseases.

Sasamura H, Itoh H.

Hypertens Res. 2012 Mar;35(3):272-3. doi: 10.1038/hr.2011.222. Epub 2012 Jan 19. No abstract available.

PMID:
22258023
10.

Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.

Azegami T, Sasamura H, Hayashi K, Itoh H.

Hypertens Res. 2012 May;35(5):492-9. doi: 10.1038/hr.2011.212. Epub 2011 Dec 8.

PMID:
22158111
11.

[Angiotensin receptor vaccines].

Sasamura H, Azegami T, Itoh H.

Nihon Rinsho. 2011 Sep;69(9):1633-8. Review. Japanese.

PMID:
21922766
12.

[Hypertension and arteriosclerosis].

Sasamura H, Itoh H.

Nihon Rinsho. 2011 Jan;69(1):125-30. Review. Japanese.

PMID:
21226272
13.

A case of IgA-related enteropathy complicated with gastrointestinal bleeding and progressive IgA nephropathy: a possible variant Henoch-Schönlein purpura?

Nakamura S, Hisamatsu T, Kikuchi J, Adachi M, Yamagishi Y, Imaeda H, Hosoe N, Naganuma M, Ebinuma H, Okamoto S, Kanai T, Ogata H, Hanaoka H, Furuya Y, Kawano Y, Bokuda K, Sasamura H, Uchida H, Endo T, Hashiguchi A, Kameyama K, Mukai M, Hibi T.

Intern Med. 2010;49(16):1755-61. Epub 2010 Aug 13. Review.

14.

Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis.

Sakamaki Y, Sasamura H, Hayashi K, Ishiguro K, Takaishi H, Okada Y, D'Armiento JM, Saruta T, Itoh H.

Nephron Exp Nephrol. 2010;115(2):e22-32. doi: 10.1159/000312883. Epub 2010 Apr 21.

PMID:
20407279
15.

Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2.

Hayashi K, Sasamura H, Ishiguro K, Sakamaki Y, Azegami T, Itoh H.

Kidney Int. 2010 Jul;78(1):69-78. doi: 10.1038/ki.2010.81. Epub 2010 Apr 7.

16.

Prevention and regression of hypertension: role of renal microvascular protection.

Sasamura H, Hayashi K, Ishiguro K, Nakaya H, Saruta T, Itoh H.

Hypertens Res. 2009 Aug;32(8):658-64. doi: 10.1038/hr.2009.85. Epub 2009 Jun 12. Review.

PMID:
19521419
17.

Discovery of anti-varicella zoster virus activity of polyether antibiotic CP-44161.

Yamagishi Y, Ueno C, Kato A, Kai H, Sasamura H, Ueno M, Sato B, Fujie A, Fujii T, Hino M, Tsujii E.

J Antibiot (Tokyo). 2009 Feb;62(2):89-93. doi: 10.1038/ja.2008.19. Epub 2009 Jan 23.

PMID:
19198636
18.

"Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.

Ishiguro K, Hayashi K, Sasamura H, Sakamaki Y, Itoh H.

Hypertension. 2009 Jan;53(1):83-9. doi: 10.1161/HYPERTENSIONAHA.108.122721. Epub 2008 Dec 1.

PMID:
19047581
19.

The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study design.

Sasamura H, Nakaya H, Julius S, Takebayashi T, Sato Y, Uno H, Takeuchi M, Ishiguro K, Murakami M, Ryuzaki M, Itoh H; STAR CAST Investigators.

Hypertens Res. 2008 Oct;31(10):1843-9. doi: 10.1291/hypres.31.1843.

PMID:
19015590
20.

Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy.

Ishiguro K, Sasamura H, Sakamaki Y, Hayashi K, Saruta T, Itoh H.

Nephron Exp Nephrol. 2008;109(1):e20-8. doi: 10.1159/000135386. Epub 2008 May 28.

PMID:
18506109
21.

A case of atypical POEMS syndrome without polyneuropathy.

Morizane R, Sasamura H, Minakuchi H, Takae Y, Kikuchi H, Yoshiya N, Hashiguchi A, Konishi K, Okamoto S, Itoh H.

Eur J Haematol. 2008 May;80(5):452-5. doi: 10.1111/j.1600-0609.2008.01045.x. Epub 2008 Feb 13.

PMID:
18284621
22.

[Case of nephrotic syndrome due to AL-type primary amyloidosis associated with renal cell carcinoma].

Takano M, Suda N, Ichihara A, Konishi K, Sasamura H, Hayashi K, Hashiguchi A, Miyajima A, Murai M, Itoh H.

Nihon Jinzo Gakkai Shi. 2007;49(8):1014-9. Japanese.

PMID:
18186230
23.
24.

[Use of angiotensin receptor blockers (ARBs) in the metabolic syndrome].

Sasamura H, Itoh H.

Nihon Rinsho. 2007 Feb;65(2):381-8. Review. Japanese.

PMID:
17302287
25.

[A case of Henoch-Schönlein purpura in a patient on hemodialysis].

Yoshino J, Sasamura H, Konishi K, Tsuji M, Suda N, Yoshida T, Monkawa T, Hayashi M, Itoh H.

Nihon Jinzo Gakkai Shi. 2007;49(1):49-53. Japanese.

PMID:
17299986
26.

[Extracellular matrix proteins and glycoproteins in the cardiovascular system].

Sasamura H, Saruta T.

Nihon Rinsho. 2006 Jul;64 Suppl 5:559-64. Review. Japanese. No abstract available.

PMID:
16897888
27.
28.
29.
30.

The novel gluconeogenesis inhibitor FR225654 that originates from Phoma sp. no. 00144. II. Biological activities.

Ohtsu Y, Sasamura H, Shibata T, Hino M, Nakajima H.

J Antibiot (Tokyo). 2005 Jul;58(7):452-5.

PMID:
16161483
31.

The novel gluconeogenesis inhibitor FR225654 that originates from Phoma sp. no. 00144. I. Taxonomy, fermentation, isolation and physico-chemical properties.

Ohtsu Y, Sasamura H, Tanaka M, Tsurumi Y, Yoshimura S, Takase S, Shibata T, Hino M, Nakajima H.

J Antibiot (Tokyo). 2005 Jul;58(7):447-51.

PMID:
16161482
32.

Use of gadolinium contrast adrenal venography for the assessment of primary aldosteronism in a patient with iodine allergy.

Sasamura H, Hashimoto S, Kuribayashi S, Ueno K, Takase A, Hayashi M, Saruta T.

Endocr J. 2004 Oct;51(5):487-92.

33.

Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma.

Sasamura H, Takahashi A, Yuan J, Kitamura H, Masumori N, Miyao N, Itoh N, Tsukamoto T.

Urology. 2004 Aug;64(2):389-93.

PMID:
15302513
34.

Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein family.

Shimizu-Hirota R, Sasamura H, Kuroda M, Kobayashi E, Saruta T.

FEBS Lett. 2004 Apr 9;563(1-3):69-74.

35.

Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migration.

Shimizu-Hirota R, Sasamura H, Kuroda M, Kobayashi E, Hayashi M, Saruta T.

Circ Res. 2004 Apr 30;94(8):1067-74. Epub 2004 Mar 18.

PMID:
15031262
36.

Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease.

Kuroda M, Sasamura H, Kobayashi E, Shimizu-Hirota R, Nakazato Y, Hayashi M, Saruta T.

Clin Nephrol. 2004 Jan;61(1):7-16.

PMID:
14964452
37.

The novel gluconeogenesis inhibitors FR225659 and related compounds that originate from Helicomyces sp. No. 19353. II. Biological profiles.

Ohtsu Y, Sasamura H, Shibata T, Nakajima H, Hino M, Fujii T.

J Antibiot (Tokyo). 2003 Aug;56(8):689-93.

38.

The novel gluconeogenesis inhibitors FR225659 and related compounds that originate from Helicomyces sp. No. 19353. I. Taxonomy, fermentation, isolation and physico-chemical properties.

Ohtsu Y, Sasamura H, Tsurumi Y, Yoshimura S, Takase S, Hashimoto M, Shibata T, Hino M, Fujii T.

J Antibiot (Tokyo). 2003 Aug;56(8):682-8.

39.

Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.

Kobayashi E, Sasamura H, Mifune M, Shimizu-Hirota R, Kuroda M, Hayashi M, Saruta T.

Kidney Int. 2003 Oct;64(4):1179-88.

40.

External beam radiation monotherapy for localized or locally advanced prostate cancer.

Takahashi A, Yanase M, Masumori N, Sasamura H, Oda T, Tanaka T, Itoh N, Tsukamoto T, Oouchi A, Hareyama M, Shirato H, Takatsuka K, Miyao N.

Jpn J Clin Oncol. 2003 Feb;33(2):73-7.

PMID:
12629057
41.

[Prevention of hypertensive renal damage by prepubertal treatment with ARB].

Sasamura H.

Nihon Rinsho. 2002 Oct;60(10):1962-7. Review. Japanese.

PMID:
12397692
42.

Glucocorticoid regulation of proteoglycan synthesis in mesangial cells.

Kuroda M, Sasamura H, Shimizu-Hirota R, Mifune M, Nakaya H, Kobayashi E, Hayashi M, Saruta T.

Kidney Int. 2002 Sep;62(3):780-9.

43.

Prepubertal treatment with angiotensin receptor blocker causes partial attenuation of hypertension and renal damage in adult Dahl salt-sensitive rats.

Nakaya H, Sasamura H, Mifune M, Shimizu-Hirota R, Kuroda M, Hayashi M, Saruta T.

Nephron. 2002 Aug;91(4):710-8.

PMID:
12138277
44.

Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma.

Sasamura H, Takahashi A, Miyao N, Yanase M, Masumori N, Kitamura H, Itoh N, Tsukamoto T.

Br J Cancer. 2002 Mar 4;86(5):768-73.

45.

Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors.

Shimizu-Hirota R, Sasamura H, Mifune M, Nakaya H, Kuroda M, Hayashi M, Saruta T.

J Am Soc Nephrol. 2001 Dec;12(12):2609-15.

46.

Examination of angiotensin II type 1 and type 2 receptor expression in human kidneys by immunohistochemistry.

Mifune M, Sasamura H, Nakazato Y, Yamaji Y, Oshima N, Saruta T.

Clin Exp Hypertens. 2001 Apr;23(3):257-66.

PMID:
11339691
47.

Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.

Sasamura H, Shimizu-Hirota R, Nakaya H, Saruta T.

Hypertens Res. 2001 Mar;24(2):165-72.

48.
49.

Analysis of Galpha protein recognition profiles of angiotensin II receptors using chimeric Galpha proteins.

Sasamura H, Mifune M, Nakaya H, Amemiya T, Hiraki T, Nishimoto I, Saruta T.

Mol Cell Endocrinol. 2000 Dec 22;170(1-2):113-21.

PMID:
11162895
50.

Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells.

Mifune M, Sasamura H, Shimizu-Hirota R, Miyazaki H, Saruta T.

Hypertension. 2000 Nov;36(5):845-50.

PMID:
11082154

Supplemental Content

Loading ...
Support Center